“targeted-genetics” Archives

Entry Author Date Location
Stop the Bleeding: Can Gene Therapy Finally Cure Hemophilia? 03/23/15 National
What Seattle Needs (Part 1): “Semi-Successful” Biotech Companies 10/06/14 Seattle
Gates Amps Up Biotech Investment, Calypso Seeks Rebound, Targeted Genetics’ Obit, & More Seattle-Area Life Sciences News 03/10/11 Seattle
Targeted Genetics, Re-invented as AmpliPhi, Bets on Anti-Bacterials, Moves HQ to London 03/09/11 Seattle
Burrill’s Bet on Seattle, Yamada Exits Gates Foundation, Stewart Parker’s New Gig, & More Seattle-Area Life Sciences News 02/17/11 Seattle
Stewart Parker Joins IDRI as New CEO, Bringing Biotech Sensibility to Global Health Effort 02/15/11 Seattle
Dendreon Survives Medicare Panel, Arch’s Ouch, RNAi Shock Wave Hits Tekmira, & More Seattle-Area Life Sciences News 11/18/10 Seattle
Targeted Genetics Seeks Merger 11/12/10 Seattle
Seattle Children’s Moves in at Prominent Biotech Address as Targeted Genetics Moves Out 08/18/10 Seattle
Ending the Suspense, Celladon’s Gene Therapy Helps Heart Failure Patients in Small Study 06/01/10 San Diego
H. Stewart Parker Joins WBBA 04/28/10 Seattle
Celladon’s Gene Therapy Passes Heart Failure Trial; Maintains Suspense on Details 04/28/10 San Diego
AVI Biopharma Ousts CEO, CombiMatrix Drops Seattle Wing, Cell Therapeutics Cans 36 Workers, & More Seattle-Area Life Sciences News 04/22/10 Seattle
Targeted Genetics Cuts 3 Directors 04/16/10 Seattle
FDA Panel Slams Cell Therapeutics, Oncothyreon Slumps, Biotech’s Healthcare Victory, & More Seattle-Area Life Sciences News 03/25/10 Seattle
OncoGenex Adds New Chairman 03/24/10 Seattle
VentiRx Nabs $25M, Gilead Deepens Seattle Roots, Sage Strikes Deal With Pfizer & More Seattle-Area Life Sciences News 01/14/10 Seattle
Targeted Genetics Exits Nasdaq 01/13/10 Seattle
A Brief Year-End Review of Seattle Biotech 12/31/09 Seattle
Dendreon Nails Down $409M, Stewart Parker Gets Itch to Return, Seattle Genetics Finds New Partner, & More Seattle-Area Life Sciences News 12/17/09 Seattle
From Russia With Love (for Biotech), Stewart Parker Gets “Antsy” to Return 12/14/09 Seattle
The Seattle Biotech Survival Index: Companies Bounce Back in Mid-2009 09/22/09 Seattle
Celladon, Developer of Gene Therapy for Heart Failure, Secures Part of $24.6M Venture Round 09/15/09 San Diego
Arena Prepares to Release Big Obesity Study, Minnow Medical Goes Into ‘Commercialization Mode,’ Metabasis Hires Strategic Adviser, & More San Diego Life Sciences News 09/10/09 San Diego
Targeted Genetics Lives On, CellCyte Charged With Fraud, Theraclone Finds HIV Weakness, & More Seattle-Area Life Sciences News 09/10/09 Seattle
Targeted Genetics Survives Brush With Death, Sells Gene Therapy IP to Genzyme for $7M 09/09/09 National
ZymoGenetics Plays Hardball, Targeted Genetics’ Legacy, Omeros Preps for Fall IPO, & More Seattle-Area Life Sciences News 08/27/09 Seattle
Biotechs Go Back to the Future by Re-Innovating Old Drugs 08/26/09 San Diego
Targeted Genetics’ Legacy: No Cures, But a Generation of Seattle Biotechies 08/25/09 Seattle
Seattle Genetics Recruits at Warp Speed, Amgen Passes Cancer Test, Stephen Friend’s Adventure & More Seattle-Area Life Sciences News 08/13/09 Seattle
Page 1 of 3 next page »